Compare Lupin with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN SUN PHARMA LUPIN/
SUN PHARMA
 
P/E (TTM) x 25.9 30.2 85.8% View Chart
P/BV x 3.2 4.0 79.7% View Chart
Dividend Yield % 0.7 1.0 70.2%  

Financials

 LUPIN   SUN PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-21
SUN PHARMA
Mar-21
LUPIN/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,122654 171.6%   
Low Rs576339 170.0%   
Sales per share (Unadj.) Rs334.2139.6 239.4%  
Earnings per share (Unadj.) Rs27.09.5 283.9%  
Cash flow per share (Unadj.) Rs46.618.2 256.2%  
Dividends per share (Unadj.) Rs6.507.50 86.7%  
Avg Dividend yield %0.81.5 50.7%  
Book value per share (Unadj.) Rs300.1193.6 155.0%  
Shares outstanding (eoy) m453.682,399.34 18.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.53.6 71.5%   
Avg P/E ratio x31.452.1 60.3%  
P/CF ratio (eoy) x18.227.3 66.8%  
Price / Book Value ratio x2.82.6 110.4%  
Dividend payout %24.078.8 30.5%   
Avg Mkt Cap Rs m385,0721,190,430 32.3%   
No. of employees `000NANA-   
Total wages/salary Rs m28,25968,622 41.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m151,630334,981 45.3%  
Other income Rs m1,3638,592 15.9%   
Total revenues Rs m152,993343,573 44.5%   
Gross profit Rs m25,66941,616 61.7%  
Depreciation Rs m8,87420,800 42.7%   
Interest Rs m1,4061,414 99.4%   
Profit before tax Rs m16,75127,994 59.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,4855,147 87.1%   
Profit after tax Rs m12,26622,847 53.7%  
Gross profit margin %16.912.4 136.3%  
Effective tax rate %26.818.4 145.6%   
Net profit margin %8.16.8 118.6%  
BALANCE SHEET DATA
Current assets Rs m139,864304,421 45.9%   
Current liabilities Rs m84,361161,456 52.2%   
Net working cap to sales %36.642.7 85.8%  
Current ratio x1.71.9 87.9%  
Inventory Days Days69149 46.4%  
Debtors Days Days10899 109.1%  
Net fixed assets Rs m94,439336,682 28.0%   
Share capital Rs m9072,399 37.8%   
"Free" reserves Rs m135,229462,229 29.3%   
Net worth Rs m136,136464,628 29.3%   
Long term debt Rs m1618,981 1.8%   
Total assets Rs m234,302641,103 36.5%  
Interest coverage x12.920.8 62.1%   
Debt to equity ratio x00 6.1%  
Sales to assets ratio x0.60.5 123.9%   
Return on assets %5.83.8 154.2%  
Return on equity %9.04.9 183.2%  
Return on capital %13.36.2 214.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m51,02784,493 60.4%   
Fx outflow Rs m21,08130,334 69.5%   
Net fx Rs m29,94654,159 55.3%   
CASH FLOW
From Operations Rs m18,21861,704 29.5%  
From Investments Rs m-12,3965,362 -231.2%  
From Financial Activity Rs m-18,853-59,805 31.5%  
Net Cashflow Rs m-13,0315,964 -218.5%  

Share Holding

Indian Promoters % 46.6 54.7 85.2%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 40.3 32.8 123.0%  
FIIs % 19.0 12.7 149.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.1 45.3 117.2%  
Shareholders   299,620 653,359 45.9%  
Pledged promoter(s) holding % 0.0 6.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   ASTRAZENECA PHARMA  SEQUENT SCIENTIFIC  PARENT.DRUGS  BAFNA PHARMA  UNJHA FORMUL  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Sep 17, 2021 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS